RaySearch Laboratories AB (publ) RSLBF Stock
RaySearch Laboratories AB (publ) Price Chart
RaySearch Laboratories AB (publ) RSLBF Financial and Trading Overview
| RaySearch Laboratories AB (publ) stock price | 24 USD |
| Previous Close | 21.17 USD |
| Open | 21.33 USD |
| Bid | 22.73 USD x 10000 |
| Ask | 24.83 USD x 30000 |
| Day's Range | 21.33 - 21.33 USD |
| 52 Week Range | 19.57 - 37.36 USD |
| Volume | 108 USD |
| Avg. Volume | 60 USD |
| Market Cap | 723.15M USD |
| Beta (5Y Monthly) | 0.932 |
| PE Ratio (TTM) | 31.83582 |
| EPS (TTM) | 0.67 USD |
| Forward Dividend & Yield | 0.43 (1.77%) |
| Ex-Dividend Date | May 8, 2026 |
| 1y Target Est | N/A |
RSLBF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | 31.83582 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.79545027 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
RaySearch Laboratories AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.932 |
| 52-Week Change | -25.11% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 37.36 USD |
| 52 Week Low | 19.57 USD |
| 50-Day Moving Average | 23.26 USD |
| 200-Day Moving Average | 24.6 USD |
RSLBF Share Statistics
| Avg. Volume (3 month) | 60 USD |
| Avg. Daily Volume (10-Days) | 250 USD |
| Shares Outstanding | 30.42M |
| Float | 28.07M |
| Short Ratio | N/A |
| % Held by Insiders | 10.84% |
| % Held by Institutions | 54.80% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4587 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 17.20% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 92.41% |
| EBITDA Margin | 26.96% |
Management Effectiveness
| Return on Assets (ttm) | 9.86% |
| Return on Equity (ttm) | 22.82% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -12.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 351.5M USD |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.67 |
| Quarterly Earnings Growth (yoy) | -6.29% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 36.19 USD |
| Current Ratio (mrq) | 1.792 |
| Book Value Per Share (mrq) | 26.815 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | 85.62M USD |
Profile of RaySearch Laboratories AB (publ)
| Country | United States |
| State | N/A |
| City | Stockholm |
| Address | EugeniavAegen 18 C |
| ZIP | 113 68 |
| Phone | 46 8 51 05 30 00 |
| Website | https://www.raysearchlabs.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 465 |
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Q&A For RaySearch Laboratories AB (publ) Stock
What is a current RSLBF stock price?
RaySearch Laboratories AB (publ) RSLBF stock price today per share is 24 USD.
How to purchase RaySearch Laboratories AB (publ) stock?
You can buy RSLBF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RaySearch Laboratories AB (publ)?
The stock symbol or ticker of RaySearch Laboratories AB (publ) is RSLBF.
Which industry does the RaySearch Laboratories AB (publ) company belong to?
The RaySearch Laboratories AB (publ) industry is Health Information Services.
How many shares does RaySearch Laboratories AB (publ) have in circulation?
The max supply of RaySearch Laboratories AB (publ) shares is 33.9M.
What is RaySearch Laboratories AB (publ) Price to Earnings Ratio (PE Ratio)?
RaySearch Laboratories AB (publ) PE Ratio is 35.82089600 now.
What was RaySearch Laboratories AB (publ) earnings per share over the trailing 12 months (TTM)?
RaySearch Laboratories AB (publ) EPS is 0.67 USD over the trailing 12 months.
Which sector does the RaySearch Laboratories AB (publ) company belong to?
The RaySearch Laboratories AB (publ) sector is Healthcare.